Montag & Caldwell’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.6M Sell
74,139
-3,444
-4% -$546K 2.53% 22
2025
Q1
$12.8M Sell
77,583
-31,240
-29% -$5.2M 2.96% 14
2024
Q4
$17.7M Sell
108,823
-9,720
-8% -$1.74M 3.78% 7
2024
Q3
$23.2M Sell
118,543
-5,289
-4% -$975K 4.7% 5
2024
Q2
$21.5M Buy
123,832
+4,934
+4% +$821K 4.34% 6
2024
Q1
$20.1M Buy
118,898
+17,585
+17% +$3.29M 3.47% 10
2023
Q4
$20M Sell
101,313
-59,310
-37% -$10.5M 3.49% 10
2023
Q3
$27.9M Sell
160,623
-6,870
-4% -$1.25M 3.59% 7
2023
Q2
$28.8M Buy
167,493
+21,942
+15% +$3.79M 3.52% 7
2023
Q1
$24.2M Sell
145,551
-435
-0.3% -$71.3K 3.25% 13
2022
Q4
$21.4M Buy
145,986
+97,366
+200% +$14.4M 3.1% 13
2022
Q3
$7.21M Buy
+48,620
New +$8.13M 1.07% 33

Other funds holding ZTS

Montag & Caldwell's ZTS Position: Q2 2025 in Review

Montag & Caldwell reduced its Zoetis (ZTS) stake by 4.4% in Q2 2025, selling an estimated $546K and leaving 74,139 shares worth $11.6M. The position accounts for 2.53% of the portfolio, ranked #22.

Montag & Caldwell first reported a position in ZTS in Q3 2022 and has held it in 12 quarters since. The position peaked at $28.8M in Q2 2023. 1,870 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Montag & Caldwell held 74,139 shares of Zoetis worth $11.6M as of Q2 2025.
  • Montag & Caldwell sold 3,444 Zoetis shares in Q2 2025, an estimated $546K.
  • Zoetis made up 2.53% of Montag & Caldwell's portfolio in Q2 2025, its #22 holding.
  • Montag & Caldwell first reported a position in Zoetis in Q3 2022 and has held it in 12 quarters since.
  • Montag & Caldwell's Zoetis position peaked at $28.8M in Q2 2023.
  • 1,870 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.